U.S. markets open in 42 minutes
  • S&P Futures

    4,412.75
    -25.25 (-0.57%)
     
  • Dow Futures

    34,476.00
    -168.00 (-0.48%)
     
  • Nasdaq Futures

    15,190.50
    -113.00 (-0.74%)
     
  • Russell 2000 Futures

    2,238.90
    -16.30 (-0.72%)
     
  • Crude Oil

    73.16
    -0.14 (-0.19%)
     
  • Gold

    1,747.00
    -2.80 (-0.16%)
     
  • Silver

    22.44
    -0.24 (-1.05%)
     
  • EUR/USD

    1.1714
    -0.0033 (-0.28%)
     
  • 10-Yr Bond

    1.4320
    +0.0220 (+1.56%)
     
  • Vix

    20.24
    -0.63 (-3.02%)
     
  • GBP/USD

    1.3669
    -0.0052 (-0.38%)
     
  • USD/JPY

    110.5470
    +0.2460 (+0.22%)
     
  • BTC-USD

    41,323.81
    -2,440.37 (-5.58%)
     
  • CMC Crypto 200

    1,026.53
    -82.39 (-7.43%)
     
  • FTSE 100

    7,049.65
    -28.70 (-0.41%)
     
  • Nikkei 225

    30,248.81
    +609.41 (+2.06%)
     

Coherus BioSciences to Report Second Quarter 2021 Financial Results on August 5th

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

REDWOOD CITY, Calif., July 26, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that its second quarter 2021 financial results will be released after market close on Thursday, August 5, 2021. Starting at 5 p.m. ET, Coherus’ management team will host a conference call and webcast to discuss financial results and provide a general business update.

After releasing second quarter financial results, the Company will post them on the Coherus website at https://investors.coherus.com.

Conference Call Information

When: Thursday, August 5, 2021 starting at 5:00 p.m. ET

Dial-in: (844) 452-6826 (Toll-Free U.S. and Canada) or (765) 507-2587 (International)

Conference ID: 9146617

Webcast: https://investors.coherus.com/upcoming-events

Please dial-in 15 minutes early to ensure a timely connection to the call.

About Coherus BioSciences
Coherus is a commercial stage biopharmaceutical company with the mission to increase access to cost-effective medicines that can have a major impact on patients’ lives and to deliver significant savings to the health care system. For additional information, please visit www.coherus.com.

CONTACT: Contact Information: Investor Contact: McDavid Stilwell, CFO Coherus BioSciences, Inc. IR@coherus.com